BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16763719)

  • 21. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulated expression of the TPĪ² isoform of the human T prostanoid receptor by the tumour suppressors FOXP1 and NKX3.1: Implications for the role of thromboxane in prostate cancer.
    O'Sullivan AG; Eivers SB; Mulvaney EP; Kinsella BT
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3153-3169. PubMed ID: 28890397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth.
    Ren S; Kang MR; Wang J; Huang V; Place RF; Sun Y; Li LC
    Prostate; 2013 Oct; 73(14):1591-601. PubMed ID: 23836514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NKX3.1 potentiates TNF-alpha/CHX-induced apoptosis of prostate cancer cells through increasing caspase-3 expression and its activity.
    Pengju Z; Weiwen C; Aiying W; Zhaobo C; Nana N; Zhaoqin H; Qingwei L; Anli J
    Biochem Biophys Res Commun; 2010 Jul; 398(3):457-61. PubMed ID: 20599703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular cloning and analysis of the human PCAN1 (GDEP) promoter.
    Liu W; Chen W; Zhang P; Yu C; Kong F; Deng J; Zhang J; Jiang A
    Cell Mol Biol Lett; 2007; 12(4):482-92. PubMed ID: 17468839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gum mastic inhibits the expression and function of the androgen receptor in prostate cancer cells.
    He ML; Yuan HQ; Jiang AL; Gong AY; Chen WW; Zhang PJ; Young CY; Zhang JY
    Cancer; 2006 Jun; 106(12):2547-55. PubMed ID: 16691616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The loss of NKX3.1 expression in testicular--and prostate--cancers is not caused by promoter hypermethylation.
    Lind GE; Skotheim RI; Fraga MF; Abeler VM; Henrique R; Saatcioglu F; Esteller M; Teixeira MR; Lothe RA
    Mol Cancer; 2005 Feb; 4(1):8. PubMed ID: 15691383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer.
    Asatiani E; Huang WX; Wang A; Rodriguez Ortner E; Cavalli LR; Haddad BR; Gelmann EP
    Cancer Res; 2005 Feb; 65(4):1164-73. PubMed ID: 15734999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.
    Bowen C; Bubendorf L; Voeller HJ; Slack R; Willi N; Sauter G; Gasser TC; Koivisto P; Lack EE; Kononen J; Kallioniemi OP; Gelmann EP
    Cancer Res; 2000 Nov; 60(21):6111-5. PubMed ID: 11085535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression studies and mutational analysis of the androgen regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium.
    Ornstein DK; Cinquanta M; Weiler S; Duray PH; Emmert-Buck MR; Vocke CD; Linehan WM; Ferretti JA
    J Urol; 2001 Apr; 165(4):1329-34. PubMed ID: 11257711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The specific expression profile of homeobox gene NKX3.1 mRNA and protein in prostate tissues and its relationship with primary prostate cancer].
    Yang GS; Wang YM; Chen ZD
    Zhonghua Nan Ke Xue; 2006 Feb; 12(2):137-40, 144. PubMed ID: 16519150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Full-length cDNA sequence and genomic organization of human NKX3A - alternative forms and regulation by both androgens and estrogens.
    Korkmaz KS; Korkmaz CG; Ragnhildstveit E; Kizildag S; Pretlow TG; Saatcioglu F
    Gene; 2000 Dec; 260(1-2):25-36. PubMed ID: 11137288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
    Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
    Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
    Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
    Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the human MSX-1 promoter and an enhancer responsible for retinoic acid induction.
    Shen R; Chen Y; Huang L; Vitale E; Solursh M
    Cell Mol Biol Res; 1994; 40(4):297-312. PubMed ID: 7866431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ETS1 regulates NKX3.1 5' promoter activity and expression in prostate cancer cells.
    Preece DM; Harvey JM; Bentel JM; Thomas MA
    Prostate; 2011 Mar; 71(4):403-14. PubMed ID: 20842667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A functional variant in NKX3.1 associated with prostate cancer susceptibility down-regulates NKX3.1 expression.
    Akamatsu S; Takata R; Ashikawa K; Hosono N; Kamatani N; Fujioka T; Ogawa O; Kubo M; Nakamura Y; Nakagawa H
    Hum Mol Genet; 2010 Nov; 19(21):4265-72. PubMed ID: 20716579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE.
    Sepulveda VA; Weigel NL; Falzon M
    Steroids; 2006 Feb; 71(2):102-15. PubMed ID: 16243370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NKX3.1 contributes to S phase entry and regulates DNA damage response (DDR) in prostate cancer cell lines.
    Erbaykent-Tepedelen B; Ozmen B; Varisli L; Gonen-Korkmaz C; Debelec-Butuner B; Muhammed Syed H; Yilmazer-Cakmak O; Korkmaz KS
    Biochem Biophys Res Commun; 2011 Oct; 414(1):123-8. PubMed ID: 21945437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.